TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Medtronic's Evolut Pro TAVR valve treating aortic stenosis

TAVR vs. SAVR: Medtronic’s Evolut platform linked to cost savings, key benefits for low-risk patients

Two new studies evaluated the long-term impact of choosing TAVR when low-risk patients present with severe aortic stenosis. 

Thumbnail

Permanent pacemaker implantation after TAVR increases healthcare costs by $24,000 per patient

Researchers say their new analysis, based on five years of U.S. data, highlights just how important it is to keep post-TAVR PPMI rates to a minimum. 

Newsweek ranked the 50 best heart hospitals in the world

Cardiologist at heart of TAVR controversy loses hospital privileges due to ‘disruptive,’ ‘inexplicable’ behavior

The doctor appealed the hospital's decision in hopes of returning to work, but that appeal was ultimately denied. 

Carrie Redick RN MSN NEA-BC, director of interventional cardiology and structural heart, Morristown Medical Center, Atlantic Health System, explains the need for financial literacy among structural heart program directors at the Transcatheter Cardiovascular therapeutics (TCT) 2023 meeting.

Why financial literacy is so important for structural heart program directors

Carrie Redick, an ICU nurse for nearly 20 years, said understanding more about financial data improved her ability to acquire funding and other resources for her program when necessary. 

Using the Sentinel cerebral protection device during valve-in-valve TAVR is associated with significant clinical improvements.

Cerebral protection devices during valve-in-valve TAVR: Cleveland Clinic cardiologists identify key benefits

Cerebral protection devices, designed to limit the risk of stroke during transcatheter aortic valve replacement, may be especially helpful when patients undergo valve-in-valve TAVR.

Thumbnail

Lawsuit resolved after cardiologist alleged he was fired over TAVR safety concerns

The veteran cardiologist had been worried that cerebral protection devices were only being used to treat TAVR patients with specific insurance plans. The lawsuit has now been resolved to the “mutual satisfaction” of both parties.

Alain Cribier, MD, a veteran interventional cardiologist known for performing the very first transcatheter aortic valve replacement (TAVR), died on Feb. 16. He was 79 years old.

Cardiology pioneer, known for performing world’s first TAVR, remembered as a ‘true visionary’

Alain Cribier, MD, a veteran interventional cardiologist out of France, died at the age of 79. The procedure he helped put on the map is arguably cardiology's most significant breakthrough in the last several decades. 

Video of Patricia Keegan, NP, Emory, explains value of the ACC TVT NCDR registry for TAVR and why it is important from both a quality monitoring standpoint and for attracting patients to your program.

Data registries have been a huge success for U.S. structural heart programs

ACC/STS National Cardiovascular Data Registry metrics reporting for TAVR is important for marketing and care quality, explains Patricia Keegan, NP, with the Emory Heart and Vascular Center.

Displaying 105 - 112 of 419
Design by Adaptive Theme